GLYCEROL TOXICITY FOR HUMAN PERITONEAL MESOTHELIAL CELLS IN CULTURE - COMPARISON WITH GLUCOSE

Glycerol has been proposed as a substitute osmotic agent for glucose in peritoneal dialysis fluids. We have compared the effect of glycerol and glucose on the function of human peritoneal mesothelial cells (HMPC) in vitro. The viability of HMPC was not affected by glycerol (up to 250 mM), whereas it was reduced by glucose in a time- and dose-dependent manner, as assessed by the LDH release. Although the incubation of HMPC with glycerol induced a dose-dependent decrease in HMPC proliferation, the effect was significantly less inhibitory than that produced by glucose. In HPMC treated with 90 mM of glycerol or glucose the incorporation of [H-3]-thymidine had reached 79.0+/-19.3% and 55.3+/-4.0% of the control (p<0.05 and p<0.01), respectively. As measured by the [methyl-C-14]-choline incorporation, the intracellular amount of newly synthesized phospholipids was reduced from (cpm/mu g cellular protein) 147+/-58 in control HPMC to 59+/-15 in cells exposed to 90 mM of glucose (p<0.01), but not affected by glycerol (163+/-65). On the other hand, both glycerol and glucose (90 mM) decreased the synthesis of proteins (as assessed by the [H-3]-proline incorporation) and interfered with potassium (Rb-86) transport mechanisms in HPMC. Our data suggest that there exist some possibly advantageous aspects of glycerol as far as mesothelial cell biocompatibility profile is concerned.